Muster AG

I see a focused business model — building materials, aggregates, ready-mixed concrete, asphalt — across roughly 50 countries on five continents. You sell to construction firms, builders' merchants, and the public sector. That is B2B with a transport-radius constraint: ~200 km for building materials, ~100 km for aggregates and concrete. That is not a buzzword, that is physics, and it actually explains why your business is local in execution and global only in scale.

Revenue 2025 is 21,460.2M EUR versus 21,156.4M EUR prior year — a thin 1.4% uplift. EBIT 3,117.5M EUR, EBIT margin 14.5% versus 13.1%. Adjusted EBIT 3,381.4M EUR at a 15.8% margin. For a heavy materials business, that is a respectable margin band — quality building materials operators run 15–20% on RCO, and you sit in the upper half. EBITDA margin 21.8%, up from 21.3%. The mechanics are coherent: you take building materials, aggregates, concrete out of the gate, you sell within a transport radius, you book it. No subscription magic, no platform pixie dust.

What I like: you call yourself a pure-play heavy materials company and the segment numbers back it up. What I miss: a clear split between volume and price contribution in the 1.4% growth. With 606M EUR of acquired revenue (a US subsidiary, a Moroccan acquisition, a bolt-on acquisition, a North American acquisition), organic revenue was actually slightly negative — that deserves to be spelled out, not buried in the M&A footnote.

Five reporting segments. Europe leads at 9,550M EUR revenue (44.5% share) with a 14.6% RCO margin. North America 5,327M EUR (24.8%) at a striking 19.6% — that is your best-margin core market. a Group area 2,622M EUR (12.2%) at 23.3% — the highest margin segment but smallest of the operating units. Asia-Pacific 3,392M EUR (15.8%) at 11.4%. And then Group Services at 1,350M EUR (6.3%) delivering just 3.0% — that is your trading/coal/petcoke book and it does what trading books do: thin margins, high turnover.

International share of revenue is 91.0%. Top-eight country exposures: USA 21.1%, UK 9.8%, Germany 9.0%, Australia 6.5%, France 5.4%, Italy 4.7%, Indonesia 4.4%, Canada 4.2%. No single country above ~21%. That is real diversification — not the kind where "international" means three German neighbours.

What the spread tells me: Region 4 at 23.3% on 2,622M EUR generates 610M EUR of segment RCO — roughly 18% of segment RCO from 12% of revenue. That is your hidden gem, but it sits in geopolitically volatile geographies. North America at 19.6% on 5,327M EUR throws off 1,045M EUR — that is your earnings anchor, and it is also where you just bought a US subsidiary. The acquisition logic checks out arithmetically.

What I miss: market share by country. You operate in ~50 countries but disclose zero market-share percentages. "One of the world's largest" is not an investment thesis. A peer like CRH gives competitive positioning by market — you do not.

Five named moats and most of them have substance. One: regional cost barriers from transport economics. That is genuine — if a building materials mill is 300 km away, it cannot economically compete in your market. Two: 19.8 billion tonnes of aggregate reserves and resources — 7.4bn t reserves plus 12.5bn t resources (PERC standard). That is a quantified, finite, irreplaceable asset and it is the kind of moat I respect — you cannot software-disrupt a limestone quarry. Three: the flagship CCS project, the world's first industrial-scale carbon-captured building materials (a low-carbon product line). First-mover advantage in a regulated decarbonisation race is real, provided regulation actually bites — and with EU ETS phasing out free allocations and CBAM live from 2026, it should.

Four: patented a recycled-materials line process for enforced carbonation. Five: diversified country portfolio. The last one is reach, not really a moat — but the first four hold up.

Sustainable products already account for 37% of revenue (roughly 7,940M EUR). That is a non-trivial share. But here is what I do not see: the price premium. What is the per-tonne uplift for a low-carbon product line versus standard CEM I? What is the gross-margin delta for a low-carbon product line? Without that number, I cannot tell you whether sustainability is a moat that earns excess returns or a cost-pass-through that merely defends share. ROIC at a record 10.4% (PY 9.9%) suggests economic value is being created — but the specific contribution of the moat is not quantified.

R&D spend of 119.8M EUR (P&L-expensed; total incl. €37.1m capitalised: 156.8M = 0.7%) equals 0.6% of revenue. For a CCS first-mover that is on the light side — peers in specialty chemicals run multiples of that. The moat narrative is credible; the reinvestment behind it is modest.

Six growth drivers, all specific, all with a causal mechanism stated: urbanisation in emerging markets, energy transition and infrastructure including data centres, low-carbon products with margin uplift, AI-driven kiln optimisation ("double-digit million EUR" savings), portfolio M&A in North America and Australia, and prefabrication driven by labour scarcity. That is a coherent driver set — not the generic "megatrends" slide deck. I credit the company for naming six specifics and zero filler.

Market dynamics are also addressed: excess capacity in Indonesia and India, EU ETS free-allocation phase-out, CBAM from 2026, demand shift toward low-carbon products. That is honest — and it is also why I cannot rate this higher. Because for all the talk about growth drivers and disruption, there is a black hole where market data should be: no market share percentage, no TAM, no SAM, no market growth rate beyond IMF GDP proxies. The extraction confirms it: "market_context_completeness — Market size: no | Market growth: no | Source: no — major disclosure gap for a DAX heavyweight." I agree with that assessment.

Concrete numbers do exist where they matter for execution: the the transformation program targets 500M EUR of annual savings by end-2026; FY2026 EBIT guidance is 3,400–3,750M EUR versus 3,381M EUR adjusted EBIT delivered in 2025; ROIC guidance is "slightly above 10%." That is operational specificity. But on the market-sizing front, you give me macro GDP and that is it. For a global top-tier player, I expect global building materials demand in Mt, your share, your share trajectory. Without it, I cannot tell whether 1.4% revenue growth is a share gain, a share loss, or a market match.

I run the numbers: your reported EBIT margin is 14.5% (3,117.5M / 21,460.2M), up from 13.1% prior year. The adjusted EBIT margin (RCO/Revenue) is 15.8% versus 15.1% — and that is the metric I anchor on, because the additional ordinary result systematically distorts the reported number. EBITDA margin sits at 21.8% versus 21.3%. For a heavy-industrial building materials and aggregates business, 15.8% RCO is genuinely good. Building materials peer benchmarks run 12–14%; you are at the upper end.

The five-year RCO trajectory is the right shape: 14.0% (2021) → 15.8% (2025), with adjusted EBIT rising from 2,614M to 3,381M — a CAGR of roughly 6.6%. That tells me pricing power is real and the the transformation program is converting to margin (500M annual savings target by end-2026). The material cost ratio improved to 36.3% from 36.7% on lower energy costs (-7%), and personnel ratio fell to 16.1%. Both are levers a quality operator should be pulling, and you are pulling them.

What stops me from giving a 5: gross margin is not separately disclosed, so I cannot decompose price vs. volume vs. mix cleanly. And Group Services at 3.0% RCO margin on 1,350M revenue is a 13-percentage-point drag below group level. A quality company would either fix that to peer levels or carve it out. Until then, I cap this at a 4.

The adjustment gap between RCO 3,381.4M and reported EBIT 3,117.5M is 263.9M — an EBIT adjustment ratio of 8.5%, down from 15.8% in the prior year. That is moving in the right direction. The bridge itself is transparently decomposed: charges total 391.5M (impairments 172.8M including 59.5M a precast acquisition goodwill, restructuring 77.9M, disposal losses 45.4M, other 95.4M) against gains of 127.6M (impairment reversals 70.5M including a UK plant site UK 45.5M, disposal gains 42.3M, other 14.7M). I appreciate the disclosure granularity.

What bothers me: the asymmetry. Charges run 3x gains, and this is the second year in a row (PY gap 436.2M). For a building materials operator with ongoing portfolio optimisation, some impairments are structural. But when restructuring is 77.9M, impairments are 172.8M, and the pattern persists, I start treating part of this as normalised cost. If I haircut RCO by, say, 30% of the recurring charge pattern, true sustainable EBIT margin sits closer to 15.2% — still good, but not 15.8%.

The EBIT-to-net-income bridge is clean: EBIT 3,117.5M + financial result -193.2M = EBT 2,924.4M; minus taxes 750.7M (25.2% effective rate) = 2,173.6M continuing operations; less 44.1M discontinued = 2,129.5M group net income. Tax rate is reasonable for the footprint. EPS at 10.92 EUR vs. 9.87 EUR is +10.6% (+€1.05), which slightly outpaces RCO growth — clean.

Cash conversion is the cleanest part of this story. Operating cash flow of 3,254.8M against EBITDA of 4,679.3M gives a CCR of 69.6% — solid for a CapEx-heavy materials business. Free cash flow at 2,109M against net income of 2,129.5M is a 99.0% conversion ratio. That is what I want to see: accounting earnings are real cash. The 5-year FCF CAGR of 16.3% (1,341M in 2022 → 2,109M in 2025) tells me this is structural, not a working-capital one-off.

RCO vs. OCF delta is 3.9% — the test threshold for earnings quality is <30%, and you are comfortably inside it. Owner earnings (OCF 3,254.8M minus D&A 1,297.9M) come in at 1,956.9M. Self-financing math: FCF 2,109M > dividend 711M > net debt repayments 439M. You can pay shareholders, service debt, and still retain ~1bn for capital allocation. That is the definition of a self-funding compounder in building materials.

One observation: receivables grew 7.3% (2,109M → 2,262M) against revenue growth of only 1.4%. DSO expanded from 36.4 to 38.5 days. Not yet a problem, but the direction is wrong — I want to see this reverse next year. Inventories went the other way (-3.0%), which is genuine working-capital discipline.

Note: Company reports CCR using Free cash flow / RCOBD. Warren Wise applies FCF / Net Income × 100%. Values may differ from company-reported figures.

Segment profitability tells a clear story. a Group area leads at 23.3% RCO margin on 2,622M revenue — pricing power in markets with structural building materials demand. North America delivers 19.6% on 5,327M, Europe 14.6% on 9,550M (the largest pool, at group-average margin), Asia-Pacific 11.4% on 3,392M. Group Services drags at 3.0% on 1,350M. The capital allocation question writes itself: Region 4 receives 161M in segment investments, North America 260M, Europe 726M. Europe is absorbing the most capital but earning a sub-peer margin — I want to understand the ROIC per segment, which you do not disclose.

ROIC at a record 10.4% (PY 9.9%, FY2023 10.3%) is moving in the right direction, with management guiding ROIC slightly above 10% for 2026. ROE is 11.3% as disclosed (PY 9.4%; ten-year overview, net income from continuing operations / equity). The earlier 10.1% was the adjacent return-on-revenue row, and the L1 recompute of 10.06% (attributable NI / year-end equity) is a narrower basis on both operands — a definition difference, not a discrepancy. Capital Employed at 24,601M, by contrast, is L1-unverified — the disclosed value differs from the operand recompute (Equity + Long-term Financial Liabilities = 26,086.5M) by 1,485.5M. The reconciliation note states the difference reflects loans/financial investments 230M and current interest-bearing receivables 185M, plus presumably averaging effects, but the gap deserves a footnote in plain English.

The IFRS 8.28 reconciliation is fine: sum of segment RCO 3,478M vs. group RCO 3,381M, gap of -97M (-2.9%) — corporate functions and intra-group eliminations. That is normal practice and transparently disclosed. No complaint there.

I look at your revenue: 21,460.2M EUR in 2025 versus 21,156.4M EUR in 2024. That is growth of 1.4%. Then I read the bridge: scope effect +606M EUR, currency -483M EUR, organic 0.9%. So the real engine — the existing assets, existing customers, existing pricing power — delivered less than one percent. The headline number is propped up by bolt-on acquisitions. That is not a quality problem per se, but it changes the narrative completely.

The regional dispersion concerns me more. Region 4 grew 14.3% to 2,622M EUR — strong. Group Services +4.2%. Europe at 9,550M EUR is essentially flat at +0.9% reported and -0.4% adjusted for scope and currency. North America, your supposed growth core, delivered +0.3% — that is statistical noise on 5,327M EUR. Asia-Pacific contracted 4.6% to 3,392M EUR. So your two largest mature markets are stagnant, and the region you just committed your biggest 10-year deal to (a regional acquisition, Australia, signed February 2026) is shrinking. Explain that sequencing to me.

Your Strategy 2030 talks of RCO growth of 7-10% per annum. I see 0.9% organic. The gap is roughly seven percentage points and you intend to close it with M&A — 96 locations acquired, 95 divested in 2025 alone. That is portfolio churn, not compounding. A quality compounder grows volumes and price organically and uses M&A as a topping. Here it looks reversed.

This is where I give you credit. EBIT moved from 2,767.9M EUR to 3,117.5M EUR — that is +12.6% on revenue growth of just 1.4%. EBIT margin expanded 140 basis points from 13.1% to 14.5%. On an adjusted basis (RCO), 3,381.4M EUR versus 3,204.1M EUR is +5.5%, with adjusted EBIT margin at 15.8% versus 15.1%. Either lens you pick, the operating leverage is real.

EBITDA (RCOBD — the company's own steering metric) tells the same story: 4,679.3M EUR versus 4,499.1M EUR, margin 21.8% versus 21.3%. ROIC moved from 9.9% to a record 10.4% — a 50 bp improvement, just above your 'around 10%' near-term threshold; the 2030 target is around 12%. The the transformation program reportedly contributed 380M EUR of savings in 2025, on track for the 500M EUR annual run-rate by end-2026. If I take that at face value, roughly half of your EBIT uplift of ~350M EUR is structural cost-out, not cyclical pricing.

The caveat: the EBIT adjustment gap is 263.9M EUR (8.5% of reported EBIT) — including the 59.5M EUR a precast acquisition goodwill impairment flagged in the auditor's KAM and the rest covering restructuring and M&A transaction costs. That gap was 436.2M EUR (15.8%) in 2024, so it is shrinking — fine. But a company that runs 96 acquisitions and 95 divestments per year will always have a structural adjustment line. I would prefer you stop calling it 'additional ordinary result'.

Your acquisition logic is coherent on paper: pure-play heavy building materials, bolt-on size, focus on North America and Australia. The 2025 deal list — a US subsidiary (USA), a Moroccan acquisition (Morocco), a North American acquisition (Canada), a US acquisition (USA), a bolt-on acquisition (Australia) — fits the strategy. Aggregate scope contribution: +606M EUR revenue and +65M EUR RCO. So implied incremental RCO margin on acquisitions is roughly 65 / 606 = 10.7% — below your group RCO margin of 15.8%. Acquired assets dilute margin on day one. That is normal, but the synergy schedule needs to materialise.

Goodwill stands at 8,826.7M EUR — 45.7% of equity of 19,300.9M EUR. The auditor explicitly flagged this ratio in the Key Audit Matters section. In 2025 you took 59.5M EUR of goodwill impairment on the a precast acquisition CGU; in 2024 it was 46.0M EUR. That is two consecutive years of write-downs on European precast — a small but recurring signal that not every past deal was priced correctly. With a regional acquisition (Australia) signed in February 2026 as your largest acquisition in a decade, the goodwill stock will rise further. I want to see headroom disclosure for every major CGU.

Portfolio churn is high: 96 new locations acquired, 95 sold or closed in 2025. Net change: +1 location. That is active portfolio management — fine — but it makes year-on-year segment comparisons noisy and the M&A 'track record' over five years is not disclosed. I cannot tell whether your historical IRR on acquisitions exceeds WACC. That is a material disclosure gap for a company where M&A contributes more to growth than the organic business.

Guidance delivery is clean. Original 2025 RCO guidance: 3,250-3,550M EUR. Mid-year narrowed to 3,300-3,500M EUR. Actual: 3,381M EUR — comfortably inside both ranges, just above the midpoint of the narrowed range (3,400M EUR). ROIC actual of 10.4% beat the 'around 10%' qualitative anchor. That is competent forecasting in a cyclical industry. No nasty surprises, no late-year warning. I value that.

The 2026 guidance is where I get cautious. RCO range 3,400-3,750M EUR — that is +0.6% at the low end and +10.9% at the high end versus the 2025 actual of 3,381M EUR. The midpoint of 3,575M EUR implies +5.7%. Revenue guidance is qualitative — 'slight growth excluding scope and currency'. ROIC 'slightly above 10%'. For a company with a Strategy 2030 ambition of 7-10% RCO CAGR, a midpoint of +5.7% is below the lower bound. You are guiding to underperform your own long-term plan.

The supports are credible: the transformation program delivering toward the 500M EUR run-rate by end-2026, active price management, a regional acquisition consolidation, and recovering core-market demand. But 'recovering core-market demand' is the one variable you do not control. With North America organic at +0.3% and Europe at -0.4% adjusted in 2025, the 2026 case rests on a cyclical turn that is not yet visible in your own segment numbers. I would prefer a wider range with a clearer split between cost-out (controllable) and volume recovery (hopeful).

I look at the leverage profile and I have very little to complain about. Net Debt of 5,715.4M EUR against EBITDA of 4,679.3M EUR gives me 1.2x — and you tell me your medium-term target is 1.5x. So you are running 0.3x below ceiling. That is genuine M&A and buyback headroom, not theoretical. Even on the broader adjusted Net Debt definition (6,383.4M EUR including pension and lease adjustments), I get 1.4x. Still inside the box.

The equity ratio of 53.4% (Equity 19,300.9M EUR / Total Assets 36,159.0M EUR) is unusually strong for a capital-intensive building materials producer. Industry peers typically operate at 35-45%. Goodwill of 8,826.7M EUR consumes 45.7% of your equity — that is a tail risk if cycle turns and you have to test cash-generating units — but tangible equity of roughly 10,474M EUR still covers Net Debt 1.8x. That is balance sheet strength I can underwrite.

One critical observation: Net Debt increased by 422.0M EUR year-on-year despite a 60M EUR FCF decline and a 400M EUR share buyback. The a Moroccan acquisition step-acquisition added 224.6M EUR of Moroccan bank loans. Your capital allocation is disciplined — buyback plus M&A plus dividend (588.8M EUR to HM AG holders, 122.2M EUR to NCI) — without breaking the leverage frame. That is what a Score 5 looks like.

I run the coverage numbers. EBIT of 3,117.5M EUR divided by gross interest expense of 224.6M EUR gives me ICR of 13.9x. Net of 72.7M EUR interest income, ICR climbs to 20.5x. Investment-grade benchmark is 4-6x. You are running roughly triple that. There is no debt service issue here — period.

DSCR check: Operating cash flow of 3,254.8M EUR against interest (224.6M EUR) plus debt repayments (1,301.4M EUR) of 1,526.0M EUR yields 2.13x. That improved from 1.66x in FY2024 — but mind the asterisk: FY2024 saw 1,736.3M EUR of repayments versus 1,301.4M EUR this year. The denominator shrank. The 2026 maturity wall of 1,386.6M EUR (bonds 1,180.1M EUR + bank loans 140.9M EUR + misc 65.6M EUR) will push the denominator back up. On a normalized basis I get DSCR closer to 1.9x — still comfortable, but not 2.13x.

FFO of 3,427.4M EUR against Net Debt of 5,715.4M EUR gives me FFO/Net Debt of 60.0%. S&P investment-grade threshold for BBB+ in this sector is typically 30-45%. You are well above. Average cost of debt at 2.7% (180.3M EUR financial interest / 6,785.6M EUR long-term financial liabilities) is favorable — the 750M EUR bond issued at 3.00% coupon for 2030 confirms you have market access at attractive levels. Cash Conversion Ratio of 0.70x (OCF/EBITDA) is the only soft spot worth flagging — but at this leverage and coverage level, it does not change the conclusion.

I look at the liquidity stack. Cash of 2,627.4M EUR against short-term financial liabilities of 1,600.9M EUR gives me a coverage ratio of 1.64x. Add the 1.92bn EUR undrawn portion of the 2bn EUR sustainability-linked syndicated facility maturing May 2029 and the 2bn EUR commercial paper programme (currently undrawn), and total available liquidity reaches approximately 6.5bn EUR. That is sufficient — but not lavish for a group of this size.

The maturity profile shows a clear 2026 spike: 1,386.6M EUR of loans (predominantly the 1,180.1M EUR bond redemption) plus 275.8M EUR of lease payments, totaling 1,662.4M EUR within 12 months. The medium bucket (one-to-five years) sums to 3,010.9M EUR of loans plus 483.1M EUR of leases. Beyond 2030, 4,225.0M EUR of loans plus 754.5M EUR of leases. The profile is reasonably laddered — no single year carries an outsized refinancing risk after 2026.

Where I become more cautious: you executed a 400M EUR share buyback tranche AND increased the dividend to 3.6 EUR/share (588.8M EUR to HM AG holders). Combined cash outflow to shareholders of nearly 1bn EUR while Net Debt simultaneously rose by 422M EUR. That is a deliberate choice to consume liquidity headroom. It is defensible at 1.2x leverage — but it means the cushion is narrower than it appears at first glance. Score 4 not 5: the cash pile is not a fortress, and the 2026 wall requires active capital markets access. If markets seize up, you depend on the undrawn facility.

I start with pensions. DBO of 2,852.7M EUR against plan assets of 2,875.1M EUR — technically overfunded by 22.4M EUR at group level. But the balance sheet shows a pension provision of 624.2M EUR (non-current 569.3 + current 54.9) AND a separate overfunding asset of 646.5M EUR booked under other non-current receivables. So overfunded plans are not netted against underfunded plans. That is IAS 19 compliant, but it inflates both sides of the balance sheet by 646.5M EUR. The net pension exposure is small — and that is good news. Pension provision declined from 714.3M EUR to 624.2M EUR YoY, reflecting plan asset performance.

Lease liabilities of 1,192.8M EUR represent 3.3% of total assets — typical for a capital-intensive business with quarries, yards, and vehicle fleets. Contingent liabilities of 174.9M EUR (mostly tax-related) plus guarantees of 32.7M EUR are immaterial against Net Debt of 5,715.4M EUR. No surprises here.

Now the rating. You state "permanent investment-grade credit rating" as a strategic anchor and frame the entire capital allocation policy around it — and you substantiate it: Moody's Baa2 (Positive) and S&P BBB (Positive) are disclosed (AR pp. 222/59/269). For a target that drives leverage policy, dividend policy, and M&A capacity, that is exactly the disclosure standard I expect from a DAX issuer — and two Positive outlooks on an investment-grade anchor are a resilience positive. The substance is fine, and so is the transparency.

Let me start with what I like. You have an explicit capital allocation hierarchy: maintain investment-grade rating, target leverage around 1.5x, ROIC target of around 12%, average annual net PP&E investment of around 1.3bn EUR by 2030. That is a framework I can hold you accountable to. ROIC delivered in FY2025 came in at a record 10.4% (FY2024: 9.9%, FY2023: 10.3%) — at your near-term 'around 10%' mark, with the around-12%-by-2030 target still 1.6pp away, and the trajectory is upward. CapEx of 1,364.6M EUR for tangible assets matches the 1.3bn EUR run-rate almost to the decimal. Execution against the framework is credible.

The capital intensity story checks out too. CapEx/Revenue at 6.4% (1,365 / 21,460) and CapEx/D&A at 1.1x (1,365 / 1,298) tells me you are reinvesting at maintenance-plus-modest-growth levels — not under-investing in the asset base, not over-extending either. With Net Debt/EBITDA stable at 1.2x for three consecutive years (FY2023: 1.2x, FY2024: 1.2x, FY2025: 1.2x), you have room before you hit the 1.5x ceiling. That headroom matters because the announced 2026 a regional acquisition deal in Australia will consume some of it.

What knocks this off a 5: the investment mix split between maintenance (1,109M EUR) and capacity expansion (1,376M EUR) is disclosed in narrative form, but I do not see a clean reconciliation to a stated decarbonisation CapEx envelope. CCS the flagship CCS site, Edmonton CCUS, a UK plant site — these are named, but the cumulative committed EUR for the decarbonisation programme is not aggregated in one place. For a sector facing CO2 transition risk, that disclosure should be sharper. A quality disclosure shows the multi-year decarbonisation CapEx commitment and the expected IRR per project — you give me names and locations, not numbers.

FY2025 M&A activity totalled approximately 867M EUR in disclosed purchase prices: a US subsidiary (USA) at 577.1M EUR, a Moroccan acquisition a Moroccan site (Morocco step-up) at 212.3M EUR cash plus 130.8M EUR fair value of the prior stake for a 343.1M EUR total cost, a bolt-on acquisition (Australia) at 56.1M EUR, a US acquisition (USA slag building materials) at 21.6M EUR. Combined acquisitions contributed 287.5M EUR revenue and 36.4M EUR profit since acquisition — pro-forma full-year would have added 151.5M EUR revenue and 5.4M EUR profit. That is a profit margin contribution in single digits on the new assets. The bolt-on focus on North America and Australia is strategically defensible — these are core markets with pricing power and disciplined competitors.

Here is what bothers me. Goodwill stands at 8,826.7M EUR — that is 45.7% of equity of 19,300.9M EUR. The auditor confirmed this ratio and flagged goodwill impairment as a Key Audit Matter. I am not telling you goodwill is bad — but at 45.7% of equity, every impairment test matters, and I do not see CGU-level headroom disclosed in absolute EUR. Goodwill additions of 593M EUR this year alone, and the synergies behind that goodwill are described qualitatively as "synergy and growth potential" — not quantified. IFRS 3.B64(q) per-deal revenue and profit contribution? Only disclosed in aggregate. For four separate acquisitions, that is the bare regulatory minimum.

The honest admission that European recycling acquisitions "fell short of expectations" while Australia "met profit expectations" deserves credit for candour — but it also deserves numbers. How much short? Which CGU? Was there an impairment trigger? The 59.5M EUR a precast acquisition impairment mentioned in the scoring rationale tells me the system is working at least partially, but I want to see the link between the admitted underperformance and the impairment testing outcomes. Track record without numbers is just a story.

One more thing. The 2026 a regional acquisition transaction in Australia is described as the largest deal in ten years. With Net Debt / EBITDA at 1.2x today and a 1.5x ceiling, the headroom is roughly 1.4bn EUR of additional debt before you breach the corridor. If a regional acquisition consumes most of that headroom, the M&A pipeline for 2027 effectively closes — or you breach your own leverage discipline. Be transparent about which path you choose.

The numbers work. Proposed dividend of 3.6 EUR per share (FY2024: 3.3 EUR, FY2023: 3.0 EUR) — a 9.1% YoY increase and a 20% cumulative increase over two years. Proposed total dividend of 635M EUR (payable 2026) against Free Cash Flow of 2,109M EUR gives an FCF payout ratio of 30.1% (635 / 2,109). On reported net income attributable of 1,940.9M EUR the payout ratio is 32.7%; on adjusted profit attributable of 2,205M EUR (which is what you anchor the policy to) it is 28.8%. Either way, this is a conservative payout that leaves substantial room for reinvestment and M&A. EPS of 10.9 EUR (FY2024: 9.9 EUR) supports the dividend with a 3.0x earnings cover.

The 400M EUR share buyback tranche on top of the dividend is the right structural choice for a capital-intensive business where you do not want to over-commit to recurring dividend obligations. Share count was reduced from 178,430,760 at year-end to 176,365,065 after the January 2026 cancellation — a 1.2% share count reduction that mechanically lifts EPS. Combined cash return to shareholders is roughly 1,035M EUR (635M proposed dividend + 400M buyback) against FCF of 2,109M EUR — a 49.1% total return ratio, leaving the other half for debt service, M&A, and growth CapEx. That is a balanced allocation.

One provenance note, now resolved. The KPI reference carried 10.1% as ROE — that is in fact the ten-year overview's return-on-revenue row (net income from continuing operations / revenue); the disclosed ROE is 11.3% (PY 9.4%; net income from continuing operations / equity). The L1 recompute of 10.06% uses attributable net income against year-end equity — a narrower basis on both operands, which explains the gap. A metric mis-mapping, not a methodology issue. Capital Employed is still L1-unverified with a 1,485.5pp gap to the recompute — that one remains open.

I look at your board stability and I see what I want to see in a long-cycle building materials business: continuity. Dr the CEO the CEO has been Chairman since February 2020 — that is roughly 6 years at the helm. His contract was extended in March 2024 until January 2028, so I have visibility on leadership through the rest of the Strategy 2030 execution window. Zero personnel changes on the Managing Board during FY2025, and the Supervisory Board extended [name withheld]'s appointment in January 2026 until 31 December 2029. Turnover rate 0.0%. For a 9-person Managing Board running a 21,460.2M EUR revenue group, that is the level of stability I expect — not the carousel I sometimes see elsewhere.

The board structure is clean: Chairman, CFO ([name withheld]), CSO ([name withheld]), CTO ([name withheld]), CDO ([name withheld]), plus four regional heads (Europe, North America, Asia & Australia, a Group area). That maps directly onto how building materials value is created — local logistics, regional pricing, plant-level execution. I see accountability lines.

Supervisory Board: 12 members, parity co-determination (6 employee representatives, 6 shareholder representatives), chaired by the Supervisory Board chair. Now — the Supervisory Board chair was your long-serving CEO before stepping up to the SB. I note this. The German code allows it after a cooling-off period, but I would prefer a chair without prior executive history at the company. That said, 98.61% plenary attendance and 100% committee attendance tell me the board is actually doing the work, not just collecting fees.

Total Managing Board remuneration came in at 39.2M EUR per IAS 24. On a 9-person board governing 21,460.2M EUR revenue and 3,117.5M EUR EBIT, that is roughly 0.18% of revenue and 1.3% of EBIT — within tolerable range for a DAX building materials major. The mix is what I want to see: Chairman 29% fixed / 71% variable; members 33% fixed / 67% variable. Two-thirds at risk is the right pressure.

The LTI design is the part I like. Virtual performance share plan (PSUs) since 2024, three-year performance period plus a one-year waiting period. Weights: EBIT 25%, ROIC 25%, relative TSR 25%, ESG 25%. ROIC at 25% directly anchors the board to capital discipline — and your ROIC of 10.4% (up from 9.9% in FY2024; 10.3% in FY2023) shows the gauge is moving in the right direction. Relative TSR at 25% keeps you honest against peers. Mandatory share acquisition (half of LTI payout must buy Muster AG shares until the Share Ownership Guideline is hit) is the kind of forced skin-in-the-game I respect.

What costs you a point: two GCGC deviations. G.10 sentence 2 — the transitional 2024 LTI tranche pays out 25% in advance in 2027. That dilutes the long-term character of the LTI for one tranche. G.13 sentence 2 — severance is not offset against the waiting allowance. Both are disclosed transparently, neither is fatal, but a quality compensation system has zero deviations. AGM approval was strong (96.21% for Managing Board system, 99.57% for SB), so shareholders have signed off. DVFA Scorecard 90.11 points, rank 14, classification "outstanding" — the external benchmark agrees with my read.

Let me be direct about the ownership setup. the anchor shareholder / the family holding Beteiligungen GmbH holds 28.4% — unchanged through FY2025. That is a blocking minority under German corporate law (anything above 25% blocks 75% AGM resolutions). Free float is 71.6%. KO-4 (majority shareholder override) is NOT triggered — the anchor shareholder is well below 50%, the CEO and SB Chair are not appointed by the anchor, and multiple minority protection mechanisms are in place.

Why I am comfortable here: AGM-approved compensation systems with 96.21% (MB) and 99.57% (SB) — those are not pushed-through votes, those are broad-based shareholder endorsements. Formal independence declaration per GCGC C.6/C.7 confirms all six shareholder representatives on the SB are independent. The Audit Committee monitors related-party transactions, and the SB consents on RPT decisions. Related-party transactions disclosed: joint ventures revenue 138.3M EUR / procurement 324.3M EUR; associates revenue 81.8M EUR / procurement 16.6M EUR. Stated as arm's-length. Services to PHOENIX Pharmahandel (the anchor shareholder-related): zero in FY2025 (prior year: 85,000 EUR — immaterial). No DPLTA, no investor agreement disclosed.

What keeps this at a 4 rather than a 5: the optics of a blocking minority combined with Dr the Supervisory Board chair (former long-serving CEO) chairing the SB. Both are code-compliant, neither is a red flag, but a pure free-float DAX company would score higher on this dimension. The 89.7% total shareholder return in 2025 — outperforming the DAX (+23.0%) by 66.7 percentage points on a TSR basis — also tells me the anchor structure is not destroying minority value. If anything, the anchor shareholder's long-term horizon aligns well with building materials's long-cycle economics.

Auditor: a Big Four audit firm (the auditor). Same firm prior year, no rotation in the last four years. Continuity is fine for me as long as the partner rotates per the EU regulation — and the disclosure shows no auditor change. No issue here.

Guidance accuracy: original FY2025 RCO guidance was 3,250–3,550M EUR. Actual RCO came in at 3,381.4M EUR (Adjusted EBIT), squarely inside the corridor but below the midpoint (3,400M EUR). EBIT (statutory) of 3,117.5M EUR is below the RCO figure — the gap is the "additional ordinary result" line of 263.9M EUR (EBIT Adjustment Gap, ratio 8.5%, down from 15.8% in FY2024). I note that the steering KPI is RCO, not EBIT — that is the management convention, and the adjustments shrank meaningfully year-on-year. For FY2026 you guide RCO 3,400–3,750M EUR; midpoint 3,575M EUR implies +5.7% versus FY2025 actual. Supported, you say, by core-market recovery, price management, and the transformation program savings (target 500M EUR annually by end-2026). I will hold you to that.

Compliance: one disclosed item — European subsidiary fined approximately 12M EUR end-2024 for alleged price-fixing 2017–2018 (contested), plus ongoing an Italian acquisition-legacy private damages claims from pre-acquisition antitrust violations. Classified as low risk. For a global building materials operator, that is unfortunately within the industry's standard risk envelope — building materials and antitrust cases are correlated. I do not see a systemic compliance failure.

Two L1-unverified items I must flag explicitly: ROE disclosed at 11.30% versus my recompute of 10.06% from Net Income Attributable / Equity — 1.24pp gap, unexplained. Capital Employed disclosed at 24,601M EUR versus recompute of 26,086.5M EUR from Equity / Long-term Financial Liabilities — gap of 1,485.5M EUR. The methodology reconciliation is not provided. For a DAX issuer, I expect every headline KPI to tie out cleanly. Investor Relations: clarify these two definitions in the next disclosure cycle.

Let me start with the hard numbers. Your R&D expense in the P&L is 119.8M EUR on revenue of 21,460.2M EUR — that is an R&D ratio of 0.6%. Add the capitalised portion of 37.1M EUR and you reach the disclosed total of 156.8M EUR, or roughly 0.7% of revenue. Prior year was 182.8M EUR. That is a decline of 26.0M EUR, or -14.2% YoY. At the same time R&D FTE fell from 776 to 723 — minus 53 people, or -6.8%. I do not see how you expand a decarbonisation roadmap with twelve CCUS projects while cutting both EUR and people.

The capitalisation ratio dropped from 29.2% to 23.6%. Below the 50% threshold, so no red flag on aggressive activation — that is the one positive. But the direction matters: either fewer projects meet the IAS 38 feasibility test, or the development pipeline itself is thinning. The annual report does not tell me which. And the carrying amount of internally generated development costs sits hidden inside the 495.0M EUR Other Intangibles line — I cannot see it separately. That is a transparency gap on a topic you market heavily.

Context matters. Construction materials is not pharma — I do not expect 15% R&D ratios. Industry peers run 0.5-1.0%. So 0.6% is in-range. But Muster AG is positioning itself as the decarbonisation leader of the sector. Leadership requires above-average investment, not below-average. With 21.5bn EUR in revenue and 3.4bn EUR adjusted EBIT, allocating only 157M EUR to R&D — and cutting it — sends a signal I would expect management to address directly. Where is the EUR commitment behind the rhetoric?

Here you have something. The a low-carbon product line carbon-captured near-zero building materials launched commercially in October 2025, drawing output from the the flagship CCS project plant (400kt/year capacity). That is not a press-release product — it is in the market. The a low-carbon product line portfolio claims up to 70% Portland building materials reduction and 75% material savings in 3D printing applications. Sustainable products reached 37.0% of group revenue and 47.0% in the building materials business line. For a sector typically labelled high-carbon and slow-moving, that is meaningful.

The CCUS pipeline is the strongest evidence of forward investment: roughly twelve industrial-scale projects across Europe, USA and Canada. the flagship CCS site operational 2025 (400kt/year), a UK plant site UK (800kt/year, 2029), Antoing Belgium (>800kt/year), Airvault France (~1Mt/year), DREAM Italy (~1Mt/year). Sum the capacity announbuilding materialss and you are well above 5Mt/year of captured CO2 by the end of the decade. If even half of these projects deliver on schedule, you have first-mover advantage in a sector that will be forced to decarbonise.

What I cannot assess: the economics. What EBIT margin do sustainable products earn versus conventional CEM I? What pricing premium does a low-carbon product line capture per tonne? Is the CCUS capex bridge funded by subsidies (EU ETS Innovation Fund, UK CCS clusters, IRA) or by your own balance sheet? The annual report tells me the projects exist; it does not tell me whether they earn a return above your 10.4% ROIC. Without that bridge, I score the portfolio strong on activity, partial on value creation. A 4 — not a 5.

Governance first: the Managing Board has a Chief Technical Officer ([name withheld]), a Chief Digital Officer ([name withheld]), and a Chief Sustainability & New Technologies Officer ([name withheld]). The Supervisory Board has a dedicated Sustainability and Innovation Committee. R&D is coordinated through three Competence Centers (Building materials, Aggregates, Readymix) plus the Global R&D department at Leimen and the HROC remote optimization center in Dallas. That is a real structure — not a single innovation officer with no budget. I credit that.

The digital platform footprint is concrete: HProduce 'Planner' deployed at >70 plants, Building materials Quality Database at 50 plants, HConnect with >40,000 monthly users serving >10,000 customers, >330 Expert Systems live. AI partnerships with Command Alkon and Giatec (SmartMix). Automated EPDs generated in 1.5 hours instead of months — that is a measurable productivity gain. These are not slideware initiatives.

What concerns me: the SAP S/4HANA migration targets coverage of ~75% of revenue by 2030. That is a five-year runway on an ERP backbone — meaning today you are still running a fragmented landscape across 48,973 employees and a perimeter that just absorbed a US subsidiary, a Moroccan acquisition and a bolt-on acquisition. Integration risk is real. And nowhere do I see disclosed ROI on the digital investments — what was the EBIT contribution of HProduce or the Expert Systems? Without ROI, I cannot distinguish between genuine value creation and overhead.

I count 24 individual risks in your Risk Report, spanning Strategic (6), Operational (6), Financial (5), Legal (5), and ESG/Climate (2). For a building materials and aggregates producer with 21,460.2M EUR in revenue and a 5,715.4M EUR net debt position, this is the catalogue I expect to see: CO2/EU ETS/CBAM regulation, energy and raw material volatility, asbestos legacy from a subsidiary, antitrust, physical and transition climate risk, IT/OT cyber. Nothing material missing.

The framework is sound. Group-wide coordination via Group Treasury, Insurance & Corporate Risk; decentralised identification by country management; standardised ERM software; quarterly reporting to the Managing Board; Monte Carlo simulation for aggregated risk-bearing capacity; section 91(2) AktG early-warning system confirmed by the external auditor. This is ISO 31000/COSO-grade governance. 16 of 24 risks (66.7%) have a classification band assigned, and 23 of 24 (95.8%) have concrete countermeasures — only natural disasters rely on the generic insurance-plus-diversification answer, which is acceptable.

The Managing Board states there is no going-concern risk, and the auditor's unqualified opinion aligns. With ICR at 13.9x, Net Debt/EBITDA at 1.2x, and FFO/Net Debt at 60.0%, that assessment is defensible from the balance sheet side.

Here is where I push back. You disclose 24 risks but EUR-quantify exactly 4: asbestos provisions at 385.0M, a European market antitrust fine at 12.0M, an interest rate sensitivity of 5.4M for a 100bp shift, and a currency sensitivity in Note 10.3. That is 16.7% quantification. The remaining 20 risks sit in 5-level impact bands (≤10M to >300M) and 5-level likelihood bands (0% to >60%) — methodologically a semi-quantitative matrix per ISO 31000, but not what I need to stress-test the investment case.

The two risks you classify as 'high' — CO2/EU ETS/CBAM regulation and IT/OT cyber — receive no EUR exposure. For a building materials producer where CO2 cost is arguably the single largest swing factor on the 3,381.4M EUR adjusted EBIT, this is a real gap. CBAM transition and EU ETS Phase 4 free-allocation phase-out have well-defined economics; tell me what they cost. The 14.5% EBIT margin is sensitive to a CO2 price move I cannot model from the disclosure.

Commodity-price sensitivity is missing entirely. Energy and raw materials are flagged 'medium', but no quantitative table is provided in the Risk Report or in Notes 10.3-10.5. Peers in construction materials disclose +/-10% energy price scenarios — you do not. Default-risk sensitivity (IFRS 9 ECL) is also absent. FX and interest rate sensitivities are present, which is the IFRS 7 minimum, but the disclosure stops there.

The externality disclosure is where Muster AG, as a building materials major, has to deliver — and it largely does. Transition risk (policy/legal, market/reputation, CCUS technology) is reported; physical climate risk (tropical cyclones, river flooding, drought, heat, precipitation stress) is reported; environmental regulatory risk (EU ETS, CBAM) is reported; social/supply chain risk including human rights sits in the sustainability statement. For a sector where carbon is the existential question, the catalogue is appropriate.

Opportunities are listed in 4 categories: strategic (M&A, growth-market positioning), operational (alternative fuels above 50% by 2030, a recycled-materials line recycling, sustainable products above 50% of revenue by 2030, a low-carbon product line near-zero building materials), financial (Green Finance Framework, Sustainability-Linked Financing), and climate-related (low-carbon products, CCUS, near-zero building materials). The targets are concrete enough — '>50% alternative fuels by 2030', '>50% sustainable products revenue by 2030' — but no EUR upside is quantified. The 6.4% CapEx/Revenue ratio (1,364.6M / 21,460.2M) gives you the firepower; what I cannot tell from this disclosure is what the EBIT uplift looks like.

What is missing on the downside: climate litigation. The Pakistan climate lawsuit and Carbon Majors joint-liability exposure are named as risks but unquantified. Given the legal trajectory in Europe and the precedent risk, IAS 37.86 maximum-reasonably-possible-loss disclosure would strengthen this section materially. The asbestos provision at 385.0M shows you can do it when the exposure is mature; do it for climate litigation too.